• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不要忽视中年人群中感染新冠病毒后的住院和死亡风险。

Do not neglect SARS-CoV-2 hospitalization and fatality risks in the middle-aged adult population.

作者信息

Lapidus Nathanael, Paireau Juliette, Levy-Bruhl Daniel, de Lamballerie Xavier, Severi Gianluca, Touvier Mathilde, Zins Marie, Cauchemez Simon, Carrat Fabrice

机构信息

Sorbonne Université, Inserm, Institut Pierre-Louis d'Epidémiologie et de Santé Publique, Département de Santé Publique, Hôpital Saint-Antoine, APHP, Paris, France.

Mathematical Modelling of Infectious Diseases Unit, Institut Pasteur, UMR2000, CNRS, Paris, France; Santé Publique France, French National Public Health Agency, Saint-Maurice, France.

出版信息

Infect Dis Now. 2021 Jun;51(4):380-382. doi: 10.1016/j.idnow.2020.12.007. Epub 2021 Jan 18.

DOI:10.1016/j.idnow.2020.12.007
PMID:33521775
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7836556/
Abstract

OBJECTIVES

This study aimed at estimating the SARS-CoV-2 infection hospitalization (IHR) and infection fatality ratios (IFR) in France.

PATIENTS AND METHODS

A serosurvey was conducted in 9782 subjects from the two French regions with the highest incidence of COVID-19 during the first wave of the pandemic and coupled with surveillance data.

RESULTS

IHR and IFR were 2.7% and 0.49% overall. Both were higher in men and increased exponentially with age. The relative risks of hospitalization and death were 2.1 (95% CI: 1.9-2.3) and 3.8 (2.4-4.2) per 10-year increase, meaning that IHR and IFR approximately doubled every 10 and 5 years, respectively. They were dramatically high in the very elderly (80-90 years: IHR: 26%, IFR: 9.2%), and also substantial in younger adults (40-50 years: IHR: 0.98%, IFR: 0.042%).

CONCLUSIONS

These findings support the need for comprehensive preventive measures to help reduce the spread of the virus, even in young or middle-aged adults.

摘要

目的

本研究旨在估算法国的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染住院率(IHR)和感染死亡率(IFR)。

患者与方法

在疫情第一波期间,对法国两个新冠病毒病发病率最高的地区的9782名受试者进行了血清学调查,并结合监测数据。

结果

总体IHR和IFR分别为2.7%和0.49%。两者在男性中均更高,且随年龄呈指数增长。每增加10岁,住院和死亡的相对风险分别为2.1(95%置信区间:1.9 - 2.3)和3.8(2.4 - 4.2),这意味着IHR和IFR分别约每10年和5年翻一番。在高龄老人(80 - 90岁:IHR:26%,IFR:9.2%)中极高,在年轻成年人(40 - 50岁:IHR:0.98%,IFR:0.042%)中也相当可观。

结论

这些发现支持了采取全面预防措施以帮助减少病毒传播的必要性,即使在年轻人或中年成年人中也是如此。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d84/7836556/b3a471040f0b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d84/7836556/b3a471040f0b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d84/7836556/b3a471040f0b/gr1.jpg

相似文献

1
Do not neglect SARS-CoV-2 hospitalization and fatality risks in the middle-aged adult population.不要忽视中年人群中感染新冠病毒后的住院和死亡风险。
Infect Dis Now. 2021 Jun;51(4):380-382. doi: 10.1016/j.idnow.2020.12.007. Epub 2021 Jan 18.
2
Dynamics of SARS-CoV-2 infection hospitalisation and infection fatality ratios over 23 months in England.英格兰 23 个月内 SARS-CoV-2 感染住院和感染病死率的动态变化。
PLoS Biol. 2023 May 25;21(5):e3002118. doi: 10.1371/journal.pbio.3002118. eCollection 2023 May.
3
Risk of hospital admission and death from first-ever SARS-CoV-2 infection by age group during the Delta and Omicron periods in British Columbia, Canada.在加拿大不列颠哥伦比亚省,德尔塔和奥密克戎变异株流行期间,不同年龄组因首次感染 SARS-CoV-2 而住院和死亡的风险。
CMAJ. 2023 Oct 30;195(42):E1427-E1439. doi: 10.1503/cmaj.230721.
4
Estimating SARS-CoV-2 infections and associated changes in COVID-19 severity and fatality.估算 SARS-CoV-2 感染以及 COVID-19 严重程度和病死率的相关变化。
Influenza Other Respir Viruses. 2023 Aug 16;17(8):e13181. doi: 10.1111/irv.13181. eCollection 2023 Aug.
5
SARS-CoV-2 infection fatality rate after the first epidemic wave in Mexico.墨西哥首轮疫情过后的 SARS-CoV-2 感染病死率。
Int J Epidemiol. 2022 May 9;51(2):429-439. doi: 10.1093/ije/dyac015.
6
Estimates and Determinants of SARS-Cov-2 Seroprevalence and Infection Fatality Ratio Using Latent Class Analysis: The Population-Based Tirschenreuth Study in the Hardest-Hit German County in Spring 2020.使用潜在类别分析估计和确定 SARS-CoV-2 血清流行率和感染病死率:2020 年春季德国受灾最严重的县特赖恩施泰因的基于人群的研究。
Viruses. 2021 Jun 10;13(6):1118. doi: 10.3390/v13061118.
7
Age- & sex-specific infection fatality ratios for COVID-19 estimated from two serially conducted community-based serosurveys, Chennai, India, 2020.2020 年印度钦奈两项连续进行的社区血清学调查估计的 COVID-19 年龄和性别特异性感染病死率。
Indian J Med Res. 2021 May;153(5&6):546-549. doi: 10.4103/ijmr.IJMR_365_21.
8
Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications.评估 COVID-19 感染病死率的年龄特异性:系统评价、荟萃分析及公共政策意义。
Eur J Epidemiol. 2020 Dec;35(12):1123-1138. doi: 10.1007/s10654-020-00698-1. Epub 2020 Dec 8.
9
The real-time infection hospitalisation and fatality risk across the COVID-19 pandemic in England.英格兰 COVID-19 大流行期间实时感染住院和病死率。
Nat Commun. 2024 May 31;15(1):4633. doi: 10.1038/s41467-024-47199-3.
10
How Many SARS-CoV-2-Infected People Require Hospitalization? Using Random Sample Testing to Better Inform Preparedness Efforts.多少感染新冠病毒的人需要住院治疗?利用随机抽样检测为准备工作提供更充分信息。
J Public Health Manag Pract. 2021;27(3):246-250. doi: 10.1097/PHH.0000000000001331.

引用本文的文献

1
Risk of hospital admission and death from first-ever SARS-CoV-2 infection by age group during the Delta and Omicron periods in British Columbia, Canada.在加拿大不列颠哥伦比亚省,德尔塔和奥密克戎变异株流行期间,不同年龄组因首次感染 SARS-CoV-2 而住院和死亡的风险。
CMAJ. 2023 Oct 30;195(42):E1427-E1439. doi: 10.1503/cmaj.230721.
2
Age-specific severity of severe acute respiratory syndrome coronavirus 2 in February 2020 to June 2021 in the Netherlands.2020 年 2 月至 2021 年 6 月期间荷兰不同年龄段严重急性呼吸综合征冠状病毒 2 型的严重程度。
Influenza Other Respir Viruses. 2023 Aug 22;17(8):e13174. doi: 10.1111/irv.13174. eCollection 2023 Aug.
3

本文引用的文献

1
Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers.五种市售血清学检测方法检测 SARS-CoV-2 抗体的性能比较及识别高中和抗体滴度个体。
J Clin Microbiol. 2021 Jan 21;59(2). doi: 10.1128/JCM.02257-20.
2
Age-specific mortality and immunity patterns of SARS-CoV-2.SARS-CoV-2 的年龄特异性死亡率和免疫模式。
Nature. 2021 Feb;590(7844):140-145. doi: 10.1038/s41586-020-2918-0. Epub 2020 Nov 2.
3
Lower prevalence of antibodies neutralizing SARS-CoV-2 in group O French blood donors.
SARS-CoV-2 IgG seroprevalence surveys in blood donors before the vaccination campaign, France 2020-2021.
2020 - 2021年法国疫苗接种运动前献血者中SARS-CoV-2 IgG血清流行率调查。
iScience. 2023 Apr 21;26(4):106222. doi: 10.1016/j.isci.2023.106222. Epub 2023 Feb 15.
4
Modelling the end of a Zero-COVID strategy using nirmatrelvir/ritonavir, vaccination and NPIs in Wallis and Futuna.使用奈玛特韦/利托那韦、疫苗接种和非药物干预措施对瓦利斯和富图纳群岛“动态清零”策略的终结进行建模。
Lancet Reg Health West Pac. 2022 Nov 14;30:100634. doi: 10.1016/j.lanwpc.2022.100634. eCollection 2023 Jan.
5
The Authors' Reply.作者回复。
Eur J Epidemiol. 2022 Oct;37(10):1085-1086. doi: 10.1007/s10654-022-00927-9. Epub 2022 Oct 26.
6
Assessing the burden of COVID-19 in developing countries: systematic review, meta-analysis and public policy implications.评估发展中国家的 COVID-19 负担:系统评价、荟萃分析和公共政策影响。
BMJ Glob Health. 2022 May;7(5). doi: 10.1136/bmjgh-2022-008477.
7
Use of COVID-19 Test Positivity Rate, Epidemiological, and Clinical Tools for Guiding Targeted Public Health Interventions.使用 COVID-19 检测阳性率、流行病学和临床工具来指导有针对性的公共卫生干预措施。
Front Public Health. 2022 Mar 16;10:821611. doi: 10.3389/fpubh.2022.821611. eCollection 2022.
8
Age-specific rate of severe and critical SARS-CoV-2 infections estimated with multi-country seroprevalence studies.用多国血清流行率研究估计特定年龄组严重和危重症 SARS-CoV-2 感染的发生率。
BMC Infect Dis. 2022 Mar 29;22(1):311. doi: 10.1186/s12879-022-07262-0.
9
Evaluating COVID-19 Booster Vaccination Strategies in a Partially Vaccinated Population: A Modeling Study.在部分接种疫苗人群中评估 COVID-19 加强疫苗接种策略:一项建模研究。
Vaccines (Basel). 2022 Mar 19;10(3):479. doi: 10.3390/vaccines10030479.
10
SARS-CoV-2 epidemic after social and economic reopening in three U.S. states reveals shifts in age structure and clinical characteristics.美国三个州重新开放社会和经济后发生的 SARS-CoV-2 疫情揭示了年龄结构和临床特征的变化。
Sci Adv. 2022 Jan 28;8(4):eabf9868. doi: 10.1126/sciadv.abf9868. Epub 2022 Jan 26.
法国 O 型血献血者中,中和 SARS-CoV-2 的抗体流行率较低。
Antiviral Res. 2020 Sep;181:104880. doi: 10.1016/j.antiviral.2020.104880. Epub 2020 Jul 15.
4
Estimating the burden of SARS-CoV-2 in France.估算法国 SARS-CoV-2 的负担。
Science. 2020 Jul 10;369(6500):208-211. doi: 10.1126/science.abc3517. Epub 2020 May 13.
5
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019.新型冠状病毒病 2019 患者的 SARS-CoV-2 抗体反应。
Clin Infect Dis. 2020 Nov 19;71(16):2027-2034. doi: 10.1093/cid/ciaa344.
6
Case fatality risk of influenza A (H1N1pdm09): a systematic review.甲型流感(H1N1pdm09)的病死率:系统评价。
Epidemiology. 2013 Nov;24(6):830-41. doi: 10.1097/EDE.0b013e3182a67448.